— Kimberly-Clark Corporation (NYSE: KMB) reported Q4 2019 earnings of $1.71 per share, vs. $1.70 expected.
— Revenues were flat at $4.6 billion, vs. $4.5 billion expected.
— Organic sales increased 3%.
— FY2020 net sales are expected to increase 1% year-on-year, including organic sales growth of 2%.
— FY2020 GAAP EPS is expected to be $5.95 to $6.65.
— FY2020 adjusted EPS is expected to be $7.10 to $7.35.
— KMB shares were down 0.62% in premarket hours.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
